Daniel Paris

Daniel Paris has a diverse work experience in the field of research and development, focusing on Alzheimer's disease and related disorders. From 1992 to 1996, they worked as a Research Assistant at CNRS URA1335, University Paris XII. In 1997, they joined the University of South Florida as an Assistant Professor, conducting studies on signal transduction pathways impacted by Aß peptides. From 2003 until now, they have been working at Roskamp Institute as a Scientist III and Head of Research and Development. Daniel'swork there involves identifying lead compounds to inhibit the production of Aß peptides and investigating their effects on Alzheimer's disease. Daniel has also developed screening assays for identifying compounds against Alzheimer's disease and angiogenesis inhibitors for anti-cancer therapies. Overall, their work aims to develop therapies for neurodegenerative disorders like Alzheimer's disease.

Daniel Paris has a strong educational background in the field of science and biology. From 1989 to 1991, they pursued a Master's degree in Biochemistry and Molecular Biology at Paris-Sud University (Paris XI). Following this, they continued their academic journey at Université Paris Cité from 1992 to 1996, where they obtained a Doctor of Science degree with a specialization in Molecular and Cellular Developmental Biology.